Andere Sprachen CNBX Pharmaceuticals Inc.

Aktien

A3DK5G

US13764M2098

CNBX

Verzögert OTC Markets Andere Börsenplätze 18:03:58 07.05.2024			% 5 Tage	% 1. Jan.
0,011 ^USD	+7,84 %		-25,17 %	-22,54 %

16.04.	CNBX Pharmaceuticals Inc. meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 29. Februar 2024	CI
12.01.	CNBX Pharmaceuticals Inc. meldet Ergebnis für das erste Quartal bis zum 30. November 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	16.04.
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	12.01.
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	30.11.
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	14.07.23
BigTime Penny Stocks: Unusual "Chatter" Watchlist (GEGI, AAPJ, CNBX, GTVH)	05.06.23
BigTime Penny Stocks: Potential Breakout Stocks - Watchlist (GNPX, CLNV, CNBX, WOEN)	02.06.23
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14.04.23
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	14.04.23
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	08.02.23
CNBX Pharmaceuticals Inc. Announces Board Resignations	08.02.23
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	13.01.23
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	13.01.23
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	29.12.22
Shaul Yemal Resigns Position as Director and Board Member Cnbx Pharmaceuticals Inc	29.12.22
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	30.11.22
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	30.11.22
CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	30.11.22
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma	08.11.22
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.	08.11.22
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy	18.10.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen CNBX Pharmaceuticals Inc.

Aktien

A3DK5G

US13764M2098

CNBX

Andere Sprachen

Filter